Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 VaccinesGlobeNewsWire • 10/01/20
Why Repligen Corporation (RGEN) Could Be an Impressive Growth StockZacks Investment Research • 09/02/20
Repligen Corporation's (RGEN) CEO Tony Hunt on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/31/20
IBD Stock Of The Day Repligen Breaks Out As It Aids In Covid-19 FightInvestors Business Daily • 07/30/20